First Case of COVID-19 in NYC, First Death Reported in Washington State
The first case of COVID-19 as a result of infection with SARS-CoV-2 was confirmed in New York City; the first death related to the infection has also been reported.
Respiratory
Respiratory
Latest News
Different Phenotypes in COVID-19 Pneumonia Proposed
Patients with COVID-19 pneumonia may present with 2 distinct phenotypes, each warranting distinct treatments.
Epidemiology of Adenovirus Outbreaks on College Campuses
Among college students, human adenoviruses should be considered as a cause for respiratory illness.
Recarbrio Noninferior to Pip/Tazo for Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia
Merck announced results from the phase 3 RESTORE-IMI 2 trial of imipenem/relebactam/cilastatin (Recarbrio™) for the treatment of adults with hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP).
Linezolid-Containing Regimen as Empiric Treatment for Moderate to Severe Nocardiosis
Linezolid use in combination therapy is effective and as safe as other firstline treatments for moderate to severe nocardiosis.
Relapse of Paracoccidioidomycosis in the Central Nervous System
A patient with a history of pulmonary paracoccidioidomycosis presented with relapsed disease in the central nervous system four years after initial treatment.
Novel Severity Scoring System for Pneumonia at ICU Admission
A parsimonious score system that accurately identified elderly and non-elderly patients with pneumonia at highest risk for mortality in the intensive care unit has been developed.
Incidence of Tuberculosis High in Children Exposed to the Disease
The incidence of developing tuberculosis is high among exposed infants and young children.
FDA Issues Statement Regarding NSAID Use and COVID-19
The FDA has issued a statement regarding the use of nonsteroidal anti-inflammatory drugs (NSAIDS) in patients with coronavirus disease 2019 (COVID-19).
Phase 1 Study of Investigational mRNA Vaccine for COVID-19 Underway
A phase 1 clinical trial evaluating an investigational vaccine for protection against coronavirus disease 2019 (COVID-19) has been initiated at the Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle.
FDA: Thermo Fisher COVID-19 Test Gets Emergency Use Authorization
The FDA has issued an Emergency Use Authorization to Thermo Fisher for its TaqPath COVID-19 Combo Kit, a diagnostic test that detects nucleic acid from SARS-CoV-2, the virus that causes coronavirus disease 2019.
Millions of Coronavirus Test Kits Available Soon, Vice President Says
Vice President Mike Pence told reporters millions of much-needed testing kits for COVID-19 are on the way to clinics and labs nationwide.
Pipeline: Investigational Therapies for COVID-19
Currently, there are no antivirals licensed by the FDA to treat patients with COVID-19.
COVID-19 in Chronic Lung Disease: What You Need to Know
We spoke with the founding director of the Center for Pulmonary Infection Research and Treatment, Charles Dela Cruz, MD, PhD, of Yale University to get a better understanding of the risks that COVID-19 may pose to patients with chronic lung disease.
FDA, FTC Crack Down on Fraudulent COVID-19 “Treatments”
Warning letters issued by the FDA and the Federal Trade Commission (FTC) have been sent to several companies selling fraudulent products claiming to treat or prevent coronavirus 2019 (COVID-19).
COVID-19 Preparation Recommendations From the COPD Foundation
The COPD Foundation released practical recommendations for patients living with COPD who may have concerns about COVID-19.
Pneumonia Mortality Not Improved With Empiric Anti-MRSA Therapy
Anti-methicillin-resistant Staphylococcus aureus (MRSA) therapy in addition to standard pneumonia therapy does not improve mortality.
CDC Updates Guidance on Evaluating, Testing for COVID-19 as More Tests Become Available
The Centers for Disease Control and Prevention has updated the guidance for evaluation of persons under investigation for coronavirus disease 2019 (COVID-19), expanding the criteria to a wider group of symptomatic patients.
Effective Contact Tracing and Isolation May Help Control COVID-19 Outbreak
Highly effective contact tracing and isolation may be viable containment strategies for a COVID-19.
FDA Authorizes Emergency Use of Certain Respirators for HCPs During COVID-19 Outbreak
More respirators, including certain N95 masks, will be made available to healthcare personnel, according to the FDA and the CDC.
Normal Dose Moxifloxacin Maintained Effectiveness in Rifampin-Resistant TB
A short, 9-month regimen of normal dose moxifloxacin maintained good effectiveness up to 24 months after therapy cessation in patients with rifampicin-resistant tuberculosis.
Want to read more?
Please login or register first to view this content.
Next post in Respiratory
